Trauma patients have reduced ex vivo flow-dependent platelet hemostatic capacity in a microfluidic model of vessel injury
Kimberly A. Thomas(Washington University in St. Louis), Susan M. Shea(University of Iowa), Philip C. Spinella, Kelly Bochicchio(Washington University in St. Louis), Grant V. Bochicchio(University of Maryland, Baltimore), Matthew D. Neal(University of Pittsburgh), Jose A. Aldana(Washington University in St. Louis), Ronit Kar(University of Pittsburgh), Ricardo A. Fonseca(Washington University in St. Louis), Rassam M. G. Rassam(University of Pittsburgh), Melissa Canas(Washington University in St. Louis), Hussain Afzal(Washington University in St. Louis), Devin M. Dishong(University of Pittsburgh), Katelin C. Rahn(University of Pittsburgh)
Cited by 7
Related Papers
Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock
|New England Journal of Medicine|2018|879
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
|Bristol Research (University of Bristol)|2021|589
Platelet-derived HMGB1 is a critical mediator of thrombosis
|Journal of Clinical Investigation|2015|364
A self-assembling hydrophobically modified chitosan capable of reversible hemostatic action
|Biomaterials|2011|241
Toll-like Receptor 4 Is Expressed on Intestinal Stem Cells and Regulates Their Proliferation and Apoptosis via the p53 Up-regulated Modulator of Apoptosis
|Journal of Biological Chemistry|2012|221